Peter Fernandes serves as Executive at Bellerophon Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Peter Fernandes has executed 10 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 9, 2022 involved exercising options for 32,500 shares valued at $0.
Peter Fernandes currently holds 32,500 shares of Bellerophon Therapeutics, Inc. (BLPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Fernandes has been a net neutral trader of BLPH stock. They have purchased $0 and sold $0 worth of shares.
Peter Fernandes's most recent insider trade was on Dec 9, 2022, when they sold 32,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.93 |
| Discretionary |
| Nov 15, 2019 | BLPH | $13.7K | Payment | 40,280 | $0.34 | Discretionary |
| Sep 25, 2018 | BLPH | $0 | Award | 119,626 | $N/A | Discretionary |
| Jun 12, 2018 | BLPH | $26.8K | Payment | 11,304 | $2.37 | Discretionary |
| Jan 12, 2018 | BLPH | $0 | Award | 31,527 | $N/A | Discretionary |
| Jan 4, 2018 | BLPH | $87.9K | Payment | 35,321 | $2.49 | Discretionary |
| Mar 16, 2017 | BLPH | $0 | Award | 82,052 | $N/A | Discretionary |
| Sep 12, 2016 | BLPH | $27.3K | Payment | 19,785 | $1.38 | Discretionary |
| Jan 19, 2016 | BLPH | $0 | Award | 53,112 | $N/A | Discretionary |